Gastrointestinal Steering Committee Roster
The Gastrointestinal Steering Committee (GISC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult gastrointestinal cancers. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The GISC's membership comprises NCTN group representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Cathy Eng, M.D., FACP
Vanderbilt University Ingram Cancer Center
Nashville, TN
Karyn A. Goodman, M.D., M.S.
Tisch Cancer Institute at Mount Sinai Hospital
New York, NY
Members
Carmen Allegra, M.D.
National Cancer Institute
Rockville, MD
Rebecca Auer, M.D., M.Sc., FRCSC
The Ottawa Hospital Research Institute
Ottawa, ON, Canada
Jordan Berlin, M.D., Ph.D.
Vanderbilt University Ingram Cancer Center
Nashville, TN
Jonathan Bleeker, M.D.
University of South Dakota Medical Center
Sioux Falls, SD
George J. Chang, M.D., M.S., FACS, FASCRS
University of Texas MD Anderson Cancer Center
Houston, TX
Yun Shin Chun, M.D.
University of Texas MD Anderson Cancer Center
Houston, TX
Ryan B. Corcoran, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Anjelica Q. Davis
Patient Advocate
Springfield, MO
Arkadiusz Dudek, M.D., Ph.D.
Health Partners Cancer Care Center
St. Paul, MN
Thomas J. George, Jr., M.D., FACP
University of Florida
Gainesville, FL
Sharlene Gill, M.D., M.P.H.
University of British Columbia
Vancouver, BC, Canada
Katherine Guthrie, Ph.D., M.S.
Fred Hutchinson Cancer Research Center
Seattle, WA
Theodore S. Hong, M.D.
Massachusetts General Hospital
Boston, MA
Hagen F. Kennecke, M.D., M.H.A., FRCPC
Providence Cancer Institute Franz Clinic
Portland, OR
Elise Kohn, M.D.
National Cancer Institute
Rockville, MD
Josh Mailman
Patient Advocate
Oakland, CA
Harvey J. Mamon, M.D., Ph.D.
Brigham and Women's Hospital
Boston, MA
Jeffrey Meyerhardt, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Margaret M. Mooney, M.D., M.B.A.
National Cancer Institute
Rockville, MD
Donna Niedzwiecki, Ph.D.
Duke University Medical Center
Durham, NC
Christopher O'Callaghan, Ph.D., D.V.M.
Queen's University
Kingston, ON, Canada
Eileen O'Reilly, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Philip Philip, M.D., Ph.D., FRCP
Karmanos Cancer Institute
Detroit, MI
Lewis R. Roberts, M.B., CH.B., Ph.D.
Mayo Clinic
Rochester, MN
Lawrence V. Rubinstein, Ph.D.
National Cancer Institute
Rockville, MD
Qian Shi, Ph.D.
Mayo Clinic
Rochester, MN
Terence Z. Wong, M.D., Ph.D.
Duke University Medical Center
Durham, NC
Gregory Yothers, Ph.D.
University of Pittsburgh
Pittsburgh, PA
NCI CCCT Program Director
Wolf Lindwasser, Ph.D.
wolf.lindwasser@nih.gov